Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10729094rdf:typepubmed:Citationlld:pubmed
pubmed-article:10729094lifeskim:mentionsumls-concept:C0007452lld:lifeskim
pubmed-article:10729094lifeskim:mentionsumls-concept:C0029045lld:lifeskim
pubmed-article:10729094lifeskim:mentionsumls-concept:C0010405lld:lifeskim
pubmed-article:10729094lifeskim:mentionsumls-concept:C0010406lld:lifeskim
pubmed-article:10729094lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:10729094lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:10729094pubmed:issue7lld:pubmed
pubmed-article:10729094pubmed:dateCreated2000-4-13lld:pubmed
pubmed-article:10729094pubmed:abstractTextIn vitro matured bovine oocytes at the metaphase-II stage were slowly frozen in phosphate buffered saline (PBS) containing 1.0 M glycerol, 1.0 M dimethylsulfoxide (DMSO) or 1.0 M propylene glycol (PROH). When thawed rapidly, more (P<0.05) oocytes were morphologically normal after being frozen with DMSO (86%) or PROH (83%) than with glycerol (62%). When inseminated in vitro with frozen-thawed bull spermatozoa, higher (P<0.05) penetration rates were observed in DMSO (79%) or PROH (76%) than in glycerol (48%). The percentages of oocytes developing to the 2-cell stage at 48 h postinsemination were also significantly (P<0.05) higher in DMSO (51%) and PROH (54%) than in glycerol (33%). However, a significant increase in the proportions of 8-cell embryos (46 vs 21 to 26%; P<0.05) at 72 h postinsemination and morulae (14 vs. 6 to 8%; P<0.05) was derived from oocytes frozen with PROH than with DMSO or glycerol. In conclusion, the type of cryoprotectant used is one of the critical factors affecting developmental competence of bovine oocytes frozen at the metaphase-II stage. For this stage of oocytes, PROH was the most effective, yielding a large number of 8-cell embryos and morulae than either glycerol or DMSO in a slow freezing method combined with a 3-step thawing protocol.lld:pubmed
pubmed-article:10729094pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10729094pubmed:languageenglld:pubmed
pubmed-article:10729094pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10729094pubmed:citationSubsetIMlld:pubmed
pubmed-article:10729094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10729094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10729094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10729094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10729094pubmed:statusMEDLINElld:pubmed
pubmed-article:10729094pubmed:monthMaylld:pubmed
pubmed-article:10729094pubmed:issn0093-691Xlld:pubmed
pubmed-article:10729094pubmed:authorpubmed-author:LiJ CJClld:pubmed
pubmed-article:10729094pubmed:authorpubmed-author:NiwaKKlld:pubmed
pubmed-article:10729094pubmed:authorpubmed-author:HwangW SWSlld:pubmed
pubmed-article:10729094pubmed:authorpubmed-author:ChungH MHMlld:pubmed
pubmed-article:10729094pubmed:authorpubmed-author:JanH HHHlld:pubmed
pubmed-article:10729094pubmed:issnTypePrintlld:pubmed
pubmed-article:10729094pubmed:volume51lld:pubmed
pubmed-article:10729094pubmed:ownerNLMlld:pubmed
pubmed-article:10729094pubmed:authorsCompleteYlld:pubmed
pubmed-article:10729094pubmed:pagination1303-10lld:pubmed
pubmed-article:10729094pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:10729094pubmed:meshHeadingpubmed-meshheading:10729094...lld:pubmed
pubmed-article:10729094pubmed:meshHeadingpubmed-meshheading:10729094...lld:pubmed
pubmed-article:10729094pubmed:meshHeadingpubmed-meshheading:10729094...lld:pubmed
pubmed-article:10729094pubmed:meshHeadingpubmed-meshheading:10729094...lld:pubmed
pubmed-article:10729094pubmed:meshHeadingpubmed-meshheading:10729094...lld:pubmed
pubmed-article:10729094pubmed:meshHeadingpubmed-meshheading:10729094...lld:pubmed
pubmed-article:10729094pubmed:meshHeadingpubmed-meshheading:10729094...lld:pubmed
pubmed-article:10729094pubmed:meshHeadingpubmed-meshheading:10729094...lld:pubmed
pubmed-article:10729094pubmed:meshHeadingpubmed-meshheading:10729094...lld:pubmed
pubmed-article:10729094pubmed:meshHeadingpubmed-meshheading:10729094...lld:pubmed
pubmed-article:10729094pubmed:meshHeadingpubmed-meshheading:10729094...lld:pubmed
pubmed-article:10729094pubmed:meshHeadingpubmed-meshheading:10729094...lld:pubmed
pubmed-article:10729094pubmed:meshHeadingpubmed-meshheading:10729094...lld:pubmed
pubmed-article:10729094pubmed:meshHeadingpubmed-meshheading:10729094...lld:pubmed
pubmed-article:10729094pubmed:year1999lld:pubmed
pubmed-article:10729094pubmed:articleTitleDevelopment of in vitro matured bovine oocytes after cryopreservation with different cryoprotectants.lld:pubmed
pubmed-article:10729094pubmed:affiliationInfertility Medical Center of CHA General Hospital, Pochon CHA University, Seoul, Korea. jmlcimc@netsgo.comlld:pubmed
pubmed-article:10729094pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10729094pubmed:publicationTypeComparative Studylld:pubmed